000 01245 a2200373 4500
005 20250513062732.0
264 0 _c19940504
008 199405s 0 0 eng d
022 _a0022-2623
024 7 _a10.1021/jm00032a003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBock, M G
245 0 0 _aSecond-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubility.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cMar 1994
300 _a722-4 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBenzodiazepines
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aModels, Biological
650 0 4 _aReceptors, Cholecystokinin
_xantagonists & inhibitors
650 0 4 _aSolubility
700 1 _aDiPardo, R M
700 1 _aMellin, E C
700 1 _aNewton, R C
700 1 _aVeber, D F
700 1 _aFreedman, S B
700 1 _aSmith, A J
700 1 _aPatel, S
700 1 _aKemp, J A
700 1 _aMarshall, G R
773 0 _tJournal of medicinal chemistry
_gvol. 37
_gno. 6
_gp. 722-4
856 4 0 _uhttps://doi.org/10.1021/jm00032a003
_zAvailable from publisher's website
999 _c8144542
_d8144542